Spongberg Alison L, Witter Jason D
Department of Environmental Sciences, Mail Stop 604, University of Toledo, Toledo, OH 43606, USA.
Sci Total Environ. 2008 Jul 1;397(1-3):148-57. doi: 10.1016/j.scitotenv.2008.02.042. Epub 2008 Apr 8.
In order to add to the current state of knowledge regarding occurrence and fate of Pharmaceutical and Personal Care Products (PPCP's) in the environment, influent, effluent and biosolids from three wastewater treatment facilities in Northwest Ohio, USA, and a stream containing effluent discharge from a rural treatment facility were analyzed. The three WWTP facilities vary in size and in community served, but are all Class B facilities. One facility was sampled multiple times in order to assess temporal variability. Twenty compounds including several classes of antibiotics, acidic pharmaceuticals, and prescribed medications were analyzed using ultrasonication extraction, SPE cleanup and liquid chromatography-electrospray ionization tandem mass spectrometry. The highest number of compounds and the greatest concentrations were found in the influent from the largest and most industrial WWTP facility. Short-term temporal variability was minimal at this facility. Many compounds, such as clarithromycin, salicylic acid and gemfibrizol were found at concentrations more than one order of magnitude higher than found in the effluent samples. Effluent waters contained elevated levels of carbamazepine, clindamycin and sulfamethoxazole. Differences in composition and concentration of effluent waters between facilities existed. Biosolid samples from two different facilities were very similar in PPCP composition, although concentrations varied. Ciprofloxacin was found in biosolids at concentrations (up to 46 mug/kg dry mass) lower than values reported elsewhere. Diclofenac survived the WWTP process and was found to persist in stream water incorporating effluent discharge. The low variability within one plant, as compared to the variability found among different wastewater treatment plants locally and in the literature is likely due to differences in population, PPCP usage, plant operations and/or local environment. These data are presented here for comparison with this emerging set of environmental compounds of concern.
为了增进对环境中药物和个人护理产品(PPCP)的发生和归宿的现有认识,对美国俄亥俄州西北部三个废水处理设施的进水、出水和生物固体,以及一条含有农村处理设施排放废水的溪流进行了分析。这三个污水处理厂规模不同,服务的社区也不同,但都是B类设施。为了评估时间变异性,对其中一个设施进行了多次采样。使用超声提取、固相萃取净化和液相色谱-电喷雾电离串联质谱法分析了20种化合物,包括几类抗生素、酸性药物和处方药。在最大且工业化程度最高的污水处理厂的进水中发现的化合物数量最多,浓度也最高。该设施的短期时间变异性最小。许多化合物,如克拉霉素、水杨酸和吉非贝齐,其浓度比出水样品中的浓度高出一个数量级以上。出水中卡马西平、克林霉素和磺胺甲恶唑的含量升高。不同设施的出水在成分和浓度上存在差异。来自两个不同设施的生物固体样品在PPCP组成上非常相似,尽管浓度有所不同。在生物固体中发现的环丙沙星浓度(最高达46微克/千克干质量)低于其他地方报道的值。双氯芬酸在污水处理过程中留存了下来,并被发现在含有排放废水的溪水中持续存在。与当地不同污水处理厂之间以及文献中发现的变异性相比,一个工厂内的变异性较低,这可能是由于人口、PPCP使用情况、工厂运营和/或当地环境的差异。此处展示这些数据是为了与这组新出现的受关注环境化合物进行比较。